Skip to main content
. 2020 May 12;11:699. doi: 10.3389/fimmu.2020.00699

Figure 5.

Figure 5

(A) OS of the whole cohort of 46 patients. (B) OS of patients receiving either 1–2 or 3–6 infusions of zoledronic acid (ZOL).